Immunotherapy drug combination stimulates immune system against resistant cancers 22 Aug 2022 A combination treatment of immunotherapy with the experimental drug guadecitabine may reverse a cancer’s resistance to immunotherapy – making it sensitive to treatment again, a new study has found. Find out more Show/Hide
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein 03 Jun 2022 A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer. Find out more Show/Hide